Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Here are some key findings: Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Northwestern Now posed five questions to the study senior author Dr
This product is not a replacement for a balanced diet, healthy lifestyle, good skincare habits, sun protection or professional healthcare advice
doi: 10.3945/an.115.011239 16 MuhamadRAkrivakiAPapagiannopoulouGZavridisPZisP
This can be a hassle for some
Patients with a BMI of 27 or higher along with weight-related health issues, such as hypertension or high cholesterol, may also qualify for tirzepatide treatment
